The complexity and rapid growth of autologous and allogeneic cell therapies presents significant new CMC challenges companies must address and overcome. Our experts share their personal experiences an…
Developing and engineering recombinant protein expression platforms are not for the faint of heart. Many variables must be considered during the development process. When cell line challenges arise, s…
Newer and more complex molecules often complicate existing downstream processes. New, innovative technologies are necessary to ensure safe, efficient, and effective capture and purification of emergin…
PRESENTED BY EVALUATING BIOPHARMA
Advances in manufacturing 4.0 including digitalization, AI, and machine learning offer biopharmaceutical company’s unique opportunities to overhaul antiquated proces…
PRESENTED BY EVALUATING BIOPHARMA
With competition heating up, companies are now looking at cost savings. Process intensification and optimization via continuous processing fills this urgent need. Ho…